LUNDBERG MAGNUS 4
4 · ONYX PHARMACEUTICALS INC · Filed Mar 13, 2013
Insider Transaction Report
Form 4
LUNDBERG MAGNUS
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-11$38.85/sh+5,000$194,250→ 17,116 total - Sale
Common Stock
2013-03-11$88.00/sh−5,000$440,000→ 12,116 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-03-11−5,000→ 0 totalExercise: $38.85From: 2005-06-08Exp: 2014-06-08→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.